$CAPR FDA decision pending, up 12.5% to $7.18 on 1,066,454 shares. Tapeboard flagged $CAPR at $6.80 pre-market gap up, +6% since flag. Thin float… https://tapeboard.com/go/bsky/scanner?utm_source=bluesky&utm_medium=post&utm_campaign=bsky-native&utm_content=capr-bk-up-scanner&utm_term=scanner&s=CAPR
November 2, 2026 at 3:13 PM
$CAPR FDA decision pending, up 12.5% to $7.18 on 1,066,454 shares. Tapeboard flagged $CAPR at $6.80 pre-market gap up, +6% since flag. Thin float… https://tapeboard.com/go/bsky/scanner?utm_source=bluesky&utm_medium=post&utm_campaign=bsky-native&utm_content=capr-bk-up-scanner&utm_term=scanner&s=CAPR
$CAPR session breakout running hot this session, verticals can fade fast on the open. Tapeboard scanner tracking the move. What level are you wat… https://tapeboard.com/go/bsky/scanner?utm_source=bluesky&utm_medium=post&utm_campaign=bsky-native&utm_content=capr-bk-up-scanner&utm_term=scanner&s=CAPR
November 2, 2026 at 5:15 PM
$CAPR session breakout running hot this session, verticals can fade fast on the open. Tapeboard scanner tracking the move. What level are you wat… https://tapeboard.com/go/bsky/scanner?utm_source=bluesky&utm_medium=post&utm_campaign=bsky-native&utm_content=capr-bk-up-scanner&utm_term=scanner&s=CAPR
$CAPR premarket gap up to $6.85 from $6.38 prior close, +8.2% on 67,502 shares. Tapeboard flagged it at $6.80 earlier this session, and it has given… https://tapeboard.com/go/bsky/scanner?utm_source=bluesky&utm_medium=post&utm_campaign=bsky-native&utm_content=capr-pm-up-tape&utm_term=scanner&s=CAPR
November 2, 2026 at 1:13 PM
$CAPR premarket gap up to $6.85 from $6.38 prior close, +8.2% on 67,502 shares. Tapeboard flagged it at $6.80 earlier this session, and it has given… https://tapeboard.com/go/bsky/scanner?utm_source=bluesky&utm_medium=post&utm_campaign=bsky-native&utm_content=capr-pm-up-tape&utm_term=scanner&s=CAPR
Capricor #$CAPR will report Q3 results on Nov 10 after the close, with a call at 4:30 p.m. ET.
The FDA date of Nov 22 remains the main catalyst.
Shares closed at $7.24 Mon: below SMA50, below SMA200, RSI 51.
Hub: www.merlintrader.com/capricor-the...
Not investment advice.
The FDA date of Nov 22 remains the main catalyst.
Shares closed at $7.24 Mon: below SMA50, below SMA200, RSI 51.
Hub: www.merlintrader.com/capricor-the...
Not investment advice.
CAPR Stock: Capricor News, Deramiocel & FDA Review
Capricor stock news and analysis: deramiocel for Duchenne muscular dystrophy, the FDA review, HOPE-3 evidence, cash, dilution and key risks for CAPR holders.
www.merlintrader.com
November 3, 2026 at 5:52 PM
Capricor #$CAPR will report Q3 results on Nov 10 after the close, with a call at 4:30 p.m. ET.
The FDA date of Nov 22 remains the main catalyst.
Shares closed at $7.24 Mon: below SMA50, below SMA200, RSI 51.
Hub: www.merlintrader.com/capricor-the...
Not investment advice.
The FDA date of Nov 22 remains the main catalyst.
Shares closed at $7.24 Mon: below SMA50, below SMA200, RSI 51.
Hub: www.merlintrader.com/capricor-the...
Not investment advice.
Ope and I found a 2022 CAPR report that's like "data shows students' sense of belonging matters". Cool.
October 29, 2026 at 11:59 PM
Ope and I found a 2022 CAPR report that's like "data shows students' sense of belonging matters". Cool.
#$CAPR Capricor's FDA target action date for deramiocel in Duchenne is November 22. The amended BLA, the upper-limb indication, cash and the open questions, from primary sources. Not investment advice.
merlintrader.beehiiv.com/p/capricor-h...
merlintrader.beehiiv.com/p/capricor-h...
Capricor heads into its November 22 FDA date for deramiocel
What the CAPR stock hub tracks ahead of the Duchenne decision: the amended BLA, the upper-limb indication, cash and the risks
merlintrader.beehiiv.com
November 4, 2026 at 10:54 AM
#$CAPR Capricor's FDA target action date for deramiocel in Duchenne is November 22. The amended BLA, the upper-limb indication, cash and the open questions, from primary sources. Not investment advice.
merlintrader.beehiiv.com/p/capricor-h...
merlintrader.beehiiv.com/p/capricor-h...
#CAPR Capricor Therapeutics to Report Third Quarter 2026 Financial Results and Provide Recent Corporate Update on November 10
https://www.stocktitan.net/news/CAPR/capricor-therapeutics-to-report-third-quarter-2026-financial-results-o0682ldyha3y.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/CAPR/capricor-therapeutics-to-report-third-quarter-2026-financial-results-o0682ldyha3y.html?utm_source=stocktitan-bluesky&utm_medium=social
At 4:30 p.m. ET on Nov. 10, Capricor will host a results call.
Results cover the quarter ended Sept. 30; management will also provide a corporate update, with a webcast replay available shortly after the call.
www.stocktitan.net
November 3, 2026 at 2:00 PM
#CAPR Capricor Therapeutics to Report Third Quarter 2026 Financial Results and Provide Recent Corporate Update on November 10
https://www.stocktitan.net/news/CAPR/capricor-therapeutics-to-report-third-quarter-2026-financial-results-o0682ldyha3y.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/CAPR/capricor-therapeutics-to-report-third-quarter-2026-financial-results-o0682ldyha3y.html?utm_source=stocktitan-bluesky&utm_medium=social
I would have worn my CAPR and kept telling her to speak up because of the fan
October 27, 2026 at 4:40 PM
I would have worn my CAPR and kept telling her to speak up because of the fan
Can't believe @capricornplatypus.bsky.social drew this I'm in love: bsky.app/profile/capr...
And a smut of today sponsored by a random pic i accidentally encountered some time ago on @r34.aranfielder.com 's profile
#genitalcircus #tadcnsfw #showtime
#genitalcircus #tadcnsfw #showtime
October 27, 2026 at 8:53 PM
Can't believe @capricornplatypus.bsky.social drew this I'm in love: bsky.app/profile/capr...
#$CAPR weekly close $6.38 (+7.6% w/w), below SMA50 $8.06 / below SMA200 $20.67, RSI 41.6. Support $5.67, resistance $8.80. Broad market sell-off Friday.
New hub updated: www.merlintrader.com/capricor-the...
New hub updated: www.merlintrader.com/capricor-the...
October 31, 2026 at 11:02 AM
#$CAPR weekly close $6.38 (+7.6% w/w), below SMA50 $8.06 / below SMA200 $20.67, RSI 41.6. Support $5.67, resistance $8.80. Broad market sell-off Friday.
New hub updated: www.merlintrader.com/capricor-the...
New hub updated: www.merlintrader.com/capricor-the...
This time we get a preview of Caprimon/Kapurimon from Digimon Card Game Booster Set 27 Ignition of X.
More at WtW- withthewill.net/threads/capr...
More at WtW- withthewill.net/threads/capr...
October 26, 2026 at 6:32 AM
This time we get a preview of Caprimon/Kapurimon from Digimon Card Game Booster Set 27 Ignition of X.
More at WtW- withthewill.net/threads/capr...
More at WtW- withthewill.net/threads/capr...
#$CAPR weekly close $6.38 (+7.6% w/w), below SMA50 $8.06 / below SMA200 $20.67, RSI 41.6. Support $5.67, resistance $8.80. Broad market sell-off Friday.
New hub updated: www.merlintrader.com/capricor-the...
New hub updated: www.merlintrader.com/capricor-the...
October 31, 2026 at 11:02 AM
#$CAPR weekly close $6.38 (+7.6% w/w), below SMA50 $8.06 / below SMA200 $20.67, RSI 41.6. Support $5.67, resistance $8.80. Broad market sell-off Friday.
New hub updated: www.merlintrader.com/capricor-the...
New hub updated: www.merlintrader.com/capricor-the...
$CAPR Nov 22: FDA target action date for deramiocel (not an assurance of approval). Oct 14: Millennium reported 2.9% as of Sep 30. Rebuilt hub with the 60-page PDF report. Not investment advice.
https://www.merlintrader.com/capricor-therapeutics-stock-hub/?v=snello
https://www.merlintrader.com/capricor-therapeutics-stock-hub/?v=snello
CAPR Stock: Capricor News, Deramiocel & FDA Review
Capricor Therapeutics stock news: November 22 FDA review date, $237.9M June cash, HOPE-3 evidence, dilution and Duchenne development risks.
www.merlintrader.com
October 29, 2026 at 11:53 PM
$CAPR Nov 22: FDA target action date for deramiocel (not an assurance of approval). Oct 14: Millennium reported 2.9% as of Sep 30. Rebuilt hub with the 60-page PDF report. Not investment advice.
https://www.merlintrader.com/capricor-therapeutics-stock-hub/?v=snello
https://www.merlintrader.com/capricor-therapeutics-stock-hub/?v=snello
$CAPR Nov 22: FDA target action date for deramiocel (not an assurance of approval). Oct 14: Millennium reported 2.9% as of Sep 30. Rebuilt hub with the 60-page PDF report. Not investment advice.
https://www.merlintrader.com/capricor-therapeutics-stock-hub/?v=snello
https://www.merlintrader.com/capricor-therapeutics-stock-hub/?v=snello
CAPR Stock: Capricor News, Deramiocel & FDA Review
Capricor Therapeutics stock news: November 22 FDA review date, $237.9M June cash, HOPE-3 evidence, dilution and Duchenne development risks.
www.merlintrader.com
October 29, 2026 at 11:53 PM
$CAPR Nov 22: FDA target action date for deramiocel (not an assurance of approval). Oct 14: Millennium reported 2.9% as of Sep 30. Rebuilt hub with the 60-page PDF report. Not investment advice.
https://www.merlintrader.com/capricor-therapeutics-stock-hub/?v=snello
https://www.merlintrader.com/capricor-therapeutics-stock-hub/?v=snello
$CAPR breakout up 9.6% to $6.29 vs $5.74 prior close on 2,163,967 shares. Tapeboard chart is up, scanner is tracking the move. What level are you… https://tapeboard.com/go/bsky/scanner?utm_source=bluesky&utm_medium=post&utm_campaign=bsky-native&utm_content=capr-bk-up-scanner&utm_term=scanner&s=CAPR
October 27, 2026 at 7:39 PM
$CAPR breakout up 9.6% to $6.29 vs $5.74 prior close on 2,163,967 shares. Tapeboard chart is up, scanner is tracking the move. What level are you… https://tapeboard.com/go/bsky/scanner?utm_source=bluesky&utm_medium=post&utm_campaign=bsky-native&utm_content=capr-bk-up-scanner&utm_term=scanner&s=CAPR
Định cư Úc hay Canada diện tay nghề? Chuyện từ buổi phỏng vấn tuyển nhân viên của CAPR canadapr.vn/dinh-cu-cana...
October 28, 2026 at 4:19 PM
Định cư Úc hay Canada diện tay nghề? Chuyện từ buổi phỏng vấn tuyển nhân viên của CAPR canadapr.vn/dinh-cu-cana...
$CAPR slipped 3.3% Friday to $5.93, below both the 50-day EMA and the 200-day, near the bottom of its 20-day range. Daily RSI 34.
Next catalyst: deramiocel PDUFA Nov 22.
$SPY $XBI. Not investment advice.
Bull/bear scenarios on JC Just Charts: https://justcharts.merlintrader.com/#CAPR
Next catalyst: deramiocel PDUFA Nov 22.
$SPY $XBI. Not investment advice.
Bull/bear scenarios on JC Just Charts: https://justcharts.merlintrader.com/#CAPR
October 26, 2026 at 5:49 AM
$CAPR slipped 3.3% Friday to $5.93, below both the 50-day EMA and the 200-day, near the bottom of its 20-day range. Daily RSI 34.
Next catalyst: deramiocel PDUFA Nov 22.
$SPY $XBI. Not investment advice.
Bull/bear scenarios on JC Just Charts: https://justcharts.merlintrader.com/#CAPR
Next catalyst: deramiocel PDUFA Nov 22.
$SPY $XBI. Not investment advice.
Bull/bear scenarios on JC Just Charts: https://justcharts.merlintrader.com/#CAPR
Reposting for Jason Arday
www.unemployednegativity.com/2026/08/capr...
www.unemployednegativity.com/2026/08/capr...
Capriciously Categorical: On Plagiarism
www.unemployednegativity.com
October 25, 2026 at 3:00 PM
Reposting for Jason Arday
www.unemployednegativity.com/2026/08/capr...
www.unemployednegativity.com/2026/08/capr...
Voce pode até questionar seus métodos, mas não os resultados...
bsky.app/profile/capr...
bsky.app/profile/capr...
O que foi o plano “Punhal Verde e Amarelo”? Veja o que a PF investigou e o que a Justiça comprovou sobre Bolsonaro.
📖 Leia a matéria clicando no link - https://mrf.lu/2vSNx
📖 Leia a matéria clicando no link - https://mrf.lu/2vSNx
October 22, 2026 at 4:46 PM
Voce pode até questionar seus métodos, mas não os resultados...
bsky.app/profile/capr...
bsky.app/profile/capr...
$CAPR Premium report, now with a downloadable 63-page PDF. FDA decision on deramiocel due Nov 22 on a narrowed upper-limb indication; Millennium now below 5% (13G/A, Oct 14).
https://www.merlintrader.com/capricor-therapeutics-stock-hub/
https://www.merlintrader.com/capricor-therapeutics-stock-hub/
Capricor ($CAPR): Third PDUFA Date, November 22, 2026
What the FDA reviews for Capricor by November 22: a narrowed upper-limb indication, a restated LVEF endpoint, a 9-3 negative advisory vote and $237.9M in cash.
www.merlintrader.com
October 26, 2026 at 1:05 PM
$CAPR Premium report, now with a downloadable 63-page PDF. FDA decision on deramiocel due Nov 22 on a narrowed upper-limb indication; Millennium now below 5% (13G/A, Oct 14).
https://www.merlintrader.com/capricor-therapeutics-stock-hub/
https://www.merlintrader.com/capricor-therapeutics-stock-hub/
$CBRS-3 $META-3 $NFLX-3 $AVGO-3 $UAL-3 $MRVL-2 $SOFI-2 $HNST-2 $AEIS-2 $ENPH-2 $APPN-2 $TSCO-2 $BAK-2 $MTSI-2 $DIA-2 $PYPL-2 $UCO-2 $VZ-2 $AAPL-2 $WHR-2 $SMH-2 $LRCX-2 $INOD-2 $CAPR-2 $SKHY-2 $AMJB-2 $GOOG-2 $HOOD-2 $EQIX-2 $BA-2 $ONON-2 $DKNG-2 $WVE-1 $BHP-1 $NVTS-1 $CAVA-1
October 27, 2026 at 8:38 PM
$CBRS-3 $META-3 $NFLX-3 $AVGO-3 $UAL-3 $MRVL-2 $SOFI-2 $HNST-2 $AEIS-2 $ENPH-2 $APPN-2 $TSCO-2 $BAK-2 $MTSI-2 $DIA-2 $PYPL-2 $UCO-2 $VZ-2 $AAPL-2 $WHR-2 $SMH-2 $LRCX-2 $INOD-2 $CAPR-2 $SKHY-2 $AMJB-2 $GOOG-2 $HOOD-2 $EQIX-2 $BA-2 $ONON-2 $DKNG-2 $WVE-1 $BHP-1 $NVTS-1 $CAVA-1
« Dernier Caprice » de Yasujiro Ozu. Critique cinéma-dvd www.lheuredelasortie.com/dernier-capr...
« OZU, rare ou inédit", tel ce " Dernier caprice", succulent
« OZU, rare ou inédit", tel ce " Dernier caprice", succulent
"Dernier Caprice" de Yasujiro Ozu. Critique cinéma-dvd - L’heure de la sortie
« OZU , rare ou inédit", tel ce " Dernier caprice", succulent
www.lheuredelasortie.com
October 24, 2026 at 9:37 AM
« Dernier Caprice » de Yasujiro Ozu. Critique cinéma-dvd www.lheuredelasortie.com/dernier-capr...
« OZU, rare ou inédit", tel ce " Dernier caprice", succulent
« OZU, rare ou inédit", tel ce " Dernier caprice", succulent
$CAPR breaking out to $6.01, down 9.0% this session on 1,997,578 shares vs $6.61 prior close. Tapeboard chart is up, scanner is tracking the move.… https://tapeboard.com/go/bsky/research/CAPR?utm_source=bluesky&utm_medium=post&utm_campaign=bsky-native&utm_content=capr-bk-dn-watch&utm_term=research
October 21, 2026 at 6:19 PM
$CAPR breaking out to $6.01, down 9.0% this session on 1,997,578 shares vs $6.61 prior close. Tapeboard chart is up, scanner is tracking the move.… https://tapeboard.com/go/bsky/research/CAPR?utm_source=bluesky&utm_medium=post&utm_campaign=bsky-native&utm_content=capr-bk-dn-watch&utm_term=research
$CAPR down 7.4% to $6.12 this session on 1.31M shares - Tapeboard chart is up, scanner is tracking the move. What level holds?
Live tape on the bre… https://tapeboard.com/go/bsky/scanner?utm_source=bluesky&utm_medium=post&utm_campaign=bsky-native&utm_content=capr-bk-dn-tape&utm_term=scanner&s=CAPR
Live tape on the bre… https://tapeboard.com/go/bsky/scanner?utm_source=bluesky&utm_medium=post&utm_campaign=bsky-native&utm_content=capr-bk-dn-tape&utm_term=scanner&s=CAPR
October 21, 2026 at 4:18 PM
$CAPR down 7.4% to $6.12 this session on 1.31M shares - Tapeboard chart is up, scanner is tracking the move. What level holds?
Live tape on the bre… https://tapeboard.com/go/bsky/scanner?utm_source=bluesky&utm_medium=post&utm_campaign=bsky-native&utm_content=capr-bk-dn-tape&utm_term=scanner&s=CAPR
Live tape on the bre… https://tapeboard.com/go/bsky/scanner?utm_source=bluesky&utm_medium=post&utm_campaign=bsky-native&utm_content=capr-bk-dn-tape&utm_term=scanner&s=CAPR
Guvernul aprobă vaccinarea de urgență a oilor și caprelor cu sprijin european
www.espress.ro/politic-inte...
www.espress.ro/politic-inte...
Guvernul aprobă vaccinarea de urgență a oilor și caprelor cu sprijin european
Astfel, Executivul a aprobat o Hotărâre prin care statul român acceptă o donație din partea Comisiei Europene constând în vaccinuri împotriva pestei micilor rumegătoare (PMR) și variolei ovine și capr...
www.espress.ro
October 23, 2026 at 7:25 AM
Guvernul aprobă vaccinarea de urgență a oilor și caprelor cu sprijin european
www.espress.ro/politic-inte...
www.espress.ro/politic-inte...